Search Results 41-50 of 5207 for ������������������,������������������������������������13984852298

  1. A Multi-center, Open-label Extension, Safety Study of Mepolizumab in Subjects With Hypereosinophilic Syndrome (HES) From Study 200622 - Mayo Clinic

    About this study. This is an open-label extension study to Study 200622.In this study subjects from Study 200622 will be continued on 4-weekly dosing with ...

  2. Study to Evaluate CCS1477 in Haematological Malignancies - Mayo Clinic

    CCS1477 is a potent, selective and orally bioavailable inhibitor of the bromodomain of p300 and CBP, critical transcriptional co-activators of genes that drive ...

  3. Gastroenterology and Hepatology at Mayo Clinic

    Hello and welcome to your appointment in Mayo Clinic's Division of Gastroenterology and Hepatology. My name is Dr. Laura Raffals and on behalf of the ...

  4. Study of [18F]FAPI-74 PET in Patients With Gastrointestinal Cancers - Mayo Clinic

    About this study. The purpose of this study is to assess the effectiveness of [18F]FAPI-74 in detecting FAP expressing cells in patients diagnosed with ...

  5. Study of Intravenous Sodium Thiosulfate in Acute Calciphylaxis Patients - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  6. Mayo Clinic

    ... . VID-20523687. Home; Randall Richardsons experience at the Bariatric Center the whole Mayo Clinic supports you. Your gift holds great power – donate ...

  7. Breast cancer - Doctors and departments - Mayo Clinic

    Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, Florida and Minnesota. Staff skilled in dozens ...

  8. Mayo Clinic Comprehensive Cancer Center — Research

    Rochester, Minn. The purpose of this study is to explore the detection of circulating tumor DNA, soluble immune markers, and the evaluation of peripheral blood ...

  9. To Assess the Effectiveness, Safety, and Tolerability of INCB000928 in Participants With Fibrodysplasia Ossificans Progressiva - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  10. GS-0976 in Adults With Nonalcoholic Steatohepatitis - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...